Immatics
Clinical-stage biopharmaceutical company developing T cell receptor-based adoptive cell therapies and bispecifics targeting cancer.
Tech & App Stack is available on paid plans
Upgrade to Silver or higher to reveal the full technology and app stack for any company.
View pricingCreate a free account to see funding visualizations and detailed round data.
Create Free AccountDec 2025
Jul 2023
Mar 2020
Oct 2017
Oct 2013
Sep 2010
Feb 2007
Oct 2005
Feb 2004
Create a free account to see which investors have funded this company.
Create Free Account
BridgeBio Pharma is a clinical-stage biopharmaceutical company developing therapies for genetic d...
Clinical-stage biopharmaceutical company developing FcRn inhibitor therapies for IgG-mediated aut...
Commercial-stage oncology company pioneering antibody drug conjugate therapies for cancer treatment.
Global clinical-stage biopharmaceutical company pursuing novel drug development platforms for rar...
Research-based development stage biopharmaceutical company that discovers and develops innovative...
Global oncology company focused on developing therapies to tackle the toughest challenges in canc...
